Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
SNM Organization

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 26 January 1996:
Vol. 271. no. 5248, pp. 509 - 512
DOI: 10.1126/science.271.5248.509

Reports

Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)

Georg F. Weber (1),  Samy Ashkar (1),  Melvin J. Glimcher,  Harvey Cantor

The CD44 family of surface receptors regulates adhesion, movement, and activation of normal and neoplastic cells. The cytokine osteopontin (Eta-1), which regulates similar cellular functions, was found to be a protein ligand of CD44. Osteopontin induces cellular chemotaxis but not homotypic aggregation, whereas the inverse is true for the interaction between CD44 and a carbohydrate ligand, hyaluronate. The different responses of cells after CD44 ligation by either osteopontin or hyaluronate may account for the independent effects of CD44 on cell migration and growth. This mechanism may also be exploited by tumor cells to promote metastasis formation.


G. F. Weber and H. Cantor, Division of Immunopathology, Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
S. Ashkar and M. J. Glimcher, Department of Orthopedic Research, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
(1) These authors contributed equally to this study.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance.
M. Riedl, G. Vila, C. Maier, A. Handisurya, S. Shakeri-Manesch, G. Prager, O. Wagner, A. Kautzky-Willer, B. Ludvik, M. Clodi, et al. (2008)
J. Clin. Endocrinol. Metab. 93, 2307-2312
   Abstract »    Full Text »    PDF »
The cell biology of bone metabolism.
H K Datta, W F Ng, J A Walker, S P Tuck, and S S Varanasi (2008)
J. Clin. Pathol. 61, 577-587
   Abstract »    Full Text »    PDF »
Soybeans Ameliolate Diabetic Nephropathy in Rats.
Y. E. Choi, S. K. Ahn, W. T. Lee, J. E. Lee, S. H. Park, B. B. Yoon, and K. A. Park (2008)
Evid. Based Complement. Altern. Med.
   Abstract »    Full Text »    PDF »
Osteopontin Regulates Actin Cytoskeleton and Contributes to Cell Proliferation in Primary Erythroblasts.
J.-A. Kang, Y. Zhou, T. L. Weis, H. Liu, J. Ulaszek, N. Satgurunathan, L. Zhou, K. van Besien, J. Crispino, A. Verma, et al. (2008)
J. Biol. Chem. 283, 6997-7006
   Abstract »    Full Text »    PDF »
The Role of Osteopontin in Recovery from Hind Limb Ischemia.
C. L. Duvall, D. Weiss, S. T. Robinson, F. M.F. Alameddine, R. E. Guldberg, and W. R. Taylor (2008)
Arterioscler. Thromb. Vasc. Biol. 28, 290-295
   Abstract »    Full Text »    PDF »
Circulating Bone Marrow-Derived Osteoblast Progenitor Cells Are Recruited to the Bone-Forming Site by the CXCR4/Stromal Cell-Derived Factor-1 Pathway.
S. Otsuru, K. Tamai, T. Yamazaki, H. Yoshikawa, and Y. Kaneda (2008)
Stem Cells 26, 223-234
   Abstract »    Full Text »    PDF »
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease.
M. Scatena, L. Liaw, and C. M. Giachelli (2007)
Arterioscler. Thromb. Vasc. Biol. 27, 2302-2309
   Abstract »    Full Text »    PDF »
Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats.
T. Uehara, T. Miyoshi, N. Tsuchiya, K. Masuno, M. Okada, S. Inoue, M. Torii, J. Yamate, and T. Maruyama (2007)
Human and Experimental Toxicology 26, 767-780
   Abstract »    PDF »
Cell Type-specific Post-translational Modifications of Mouse Osteopontin Are Associated with Different Adhesive Properties.
B. Christensen, C. C. Kazanecki, T. E. Petersen, S. R. Rittling, D. T. Denhardt, and E. S. Sorensen (2007)
J. Biol. Chem. 282, 19463-19472
   Abstract »    Full Text »    PDF »
Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases.
M. Zoller, P. Gupta, R. Marhaba, M. Vitacolonna, and P. Freyschmidt-Paul (2007)
J. Leukoc. Biol. 82, 57-71
   Abstract »    Full Text »    PDF »
Galectin-9 Inhibits CD44-Hyaluronan Interaction and Suppresses a Murine Model of Allergic Asthma.
S. Katoh, N. Ishii, A. Nobumoto, K. Takeshita, S.-Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, et al. (2007)
Am. J. Respir. Crit. Care Med. 176, 27-35
   Abstract »    Full Text »    PDF »
The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer.
L. R. Rodrigues, J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson (2007)
Cancer Epidemiol. Biomarkers Prev. 16, 1087-1097
   Abstract »    Full Text »    PDF »
Human Macrophages Promote the Motility and Invasiveness of Osteopontin-Knockdown Tumor Cells.
J. Cheng, D.-H. Huo, D.-M. Kuang, J. Yang, L. Zheng, and S.-M. Zhuang (2007)
Cancer Res. 67, 5141-5147
   Abstract »    Full Text »    PDF »
The conceptus increases secreted phosphoprotein 1 gene expression in the mouse uterus during the progression of decidualization mainly due to its effects on uterine natural killer cells.
J. L Herington and B. M Bany (2007)
Reproduction 133, 1213-1221
   Abstract »    Full Text »    PDF »
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
C.-Y. Wu, M.-S. Wu, E.-P. Chiang, C.-C. Wu, Y.-J. Chen, C.-J. Chen, N.-H. Chi, G.-H. Chen, and J.-T. Lin (2007)
Gut 56, 782-789
   Abstract »    Full Text »    PDF »
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells.
S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley (2007)
J. Biol. Chem. 282, 16667-16680
   Abstract »    Full Text »    PDF »
Osteopontin Aggravates Experimental Autoimmune Uveoretinitis in Mice.
M. Kitamura, K. Iwabuchi, N. Kitaichi, S. Kon, H. Kitamei, K. Namba, K. Yoshida, D. T. Denhardt, S. R. Rittling, S. Ohno, et al. (2007)
J. Immunol. 178, 6567-6572
   Abstract »    Full Text »    PDF »
Osteopontin Promotes Integrin Activation through Outside-In and Inside-Out Mechanisms: OPN-CD44V Interaction Enhances Survival in Gastrointestinal Cancer Cells.
J.-L. Lee, M.-J. Wang, P.-R. Sudhir, G.-D. Chen, C.-W. Chi, and J.-Y. Chen (2007)
Cancer Res. 67, 2089-2097
   Abstract »    Full Text »    PDF »
Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin.
Y. Tanaka, M. Abe, M. Hiasa, A. Oda, H. Amou, A. Nakano, K. Takeuchi, K. Kitazoe, S. Kido, D. Inoue, et al. (2007)
Clin. Cancer Res. 13, 816-823
   Abstract »    Full Text »    PDF »
Urothelial CD44 Facilitates Escherichia coli Infection of the Murine Urinary Tract.
K. M. A. Rouschop, M. Sylva, G. J. D. Teske, I. Hoedemaeker, S. T. Pals, J. J. Weening, T. van der Poll, and S. Florquin (2006)
J. Immunol. 177, 7225-7232
   Abstract »    Full Text »    PDF »
Primary Glioblastomas Express Mesenchymal Stem-Like Properties.
C.-L. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, Z. Chen, K. Yoshimoto, P. S. Mischel, T. F. Cloughesy, L. M. Liau, et al. (2006)
Mol. Cancer Res. 4, 607-619
   Abstract »    Full Text »    PDF »
Osteopontin Induction of Hyaluronan Synthase 2 Expression Promotes Breast Cancer Malignancy.
A. C. Cook, A. F. Chambers, E. A. Turley, and A. B. Tuck (2006)
J. Biol. Chem. 281, 24381-24389
   Abstract »    Full Text »    PDF »
Ets-1 and Runx2 Regulate Transcription of a Metastatic Gene, Osteopontin, in Murine Colorectal Cancer Cells.
P. Y. Wai, Z. Mi, C. Gao, H. Guo, C. Marroquin, and P. C. Kuo (2006)
J. Biol. Chem. 281, 18973-18982
   Abstract »    Full Text »    PDF »
The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C {alpha}/c-Src/I{kappa}B Kinase {alpha}/{beta}-Dependent Prostate Tumor Progression and Angiogenesis..
S. Jain, G. Chakraborty, and G. C. Kundu (2006)
Cancer Res. 66, 6638-6648
   Abstract »    Full Text »    PDF »
Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer.
A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al. (2006)
Am. J. Pathol. 169, 233-246
   Abstract »    Full Text »    PDF »
Osteopontin Is an Oncogenic Vav1- but not Wild-type Vav1-Responsive Gene: Implications for Fibroblast Transformation..
V. Schapira, G. Lazer, and S. Katzav (2006)
Cancer Res. 66, 6183-6191
   Abstract »    Full Text »    PDF »
Use of CD44 by CD4+ Th1 and Th2 lymphocytes to roll and adhere.
C. S. Bonder, S. R. Clark, M. U. Norman, P. Johnson, and P. Kubes (2006)
Blood 107, 4798-4806
   Abstract »    Full Text »    PDF »
Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice.
M. Schroeter, P. Zickler, D. T. Denhardt, H.-P. Hartung, and S. Jander (2006)
Brain 129, 1426-1437
   Abstract »    Full Text »    PDF »
Crystal Retention in Renal Stone Disease: A Crucial Role for the Glycosaminoglycan Hyaluronan?.
C. F. Verkoelen (2006)
J. Am. Soc. Nephrol. 17, 1673-1687
   Abstract »    Full Text »    PDF »
CD44 is a phagocytic receptor.
E. Vachon, R. Martin, J. Plumb, V. Kwok, R. W. Vandivier, M. Glogauer, A. Kapus, X. Wang, C.-W. Chow, S. Grinstein, et al. (2006)
Blood 107, 4149-4158
   Abstract »    Full Text »    PDF »
Osteopontin and mucosal protection..
J. Sodek, A. P. Batista Da Silva, and R. Zohar (2006)
J. Dent. Res. 85, 404-415
   Abstract »    Full Text »    PDF »
Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness.
A. Celetti, D. Testa, S. Staibano, F. Merolla, V. Guarino, M. D. Castellone, R. Iovine, G. Mansueto, P. Somma, G. De Rosa, et al. (2005)
Clin. Cancer Res. 11, 8019-8027
   Abstract »    Full Text »    PDF »
Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis.
T. Yoshida, H. Hanawa, K. Toba, H. Watanabe, R. Watanabe, K. Yoshida, S. Abe, K. Kato, M. Kodama, and Y. Aizawa (2005)
Cardiovasc Res 68, 278-288
   Abstract »    Full Text »    PDF »
Osteopontin Expression and Prognostic Significance in Non-Small Cell Lung Cancer.
V. Donati, L. Boldrini, M. Dell'Omodarme, M. C. Prati, P. Faviana, T. Camacci, M. Lucchi, A. Mussi, M. Santoro, F. Basolo, et al. (2005)
Clin. Cancer Res. 11, 6459-6465
   Abstract »    Full Text »    PDF »
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells.
S. K. Nilsson, H. M. Johnston, G. A. Whitty, B. Williams, R. J. Webb, D. T. Denhardt, I. Bertoncello, L. J. Bendall, P. J. Simmons, and D. N. Haylock (2005)
Blood 106, 1232-1239
   Abstract »    Full Text »    PDF »
Bcr-Abl regulates osteopontin transcription via Ras, PI-3K, aPKC, Raf-1, and MEK.
F. B. Hickey, K. England, and T. G. Cotter (2005)
J. Leukoc. Biol. 78, 289-300
   Abstract »    Full Text »    PDF »
Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non-Small Cell Lung Cancer.
Z. Hu, D. Lin, J. Yuan, T. Xiao, H. Zhang, W. Sun, N. Han, Y. Ma, X. Di, M. Gao, et al. (2005)
Clin. Cancer Res. 11, 4646-4652
   Abstract »    Full Text »    PDF »
Protection against Renal Ischemia Reperfusion Injury by CD44 Disruption.
K. M. A. Rouschop, J. J.T.H. Roelofs, N. Claessen, P. d. C. Martins, J.-J. Zwaginga, S. T. Pals, J. J. Weening, and S. Florquin (2005)
J. Am. Soc. Nephrol. 16, 2034-2043
   Abstract »    Full Text »    PDF »
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size.
S. Stier, Y. Ko, R. Forkert, C. Lutz, T. Neuhaus, E. Grunewald, T. Cheng, D. Dombkowski, L. M. Calvi, S. R. Rittling, et al. (2005)
J. Exp. Med. 201, 1781-1791
   Abstract »    Full Text »    PDF »
Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus.
C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. Li, and C. W. K. Lam (2005)
Rheumatology 44, 602-606
   Abstract »    Full Text »    PDF »
Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
P. Y. Wai, Z. Mi, H. Guo, S. Sarraf-Yazdi, C. Gao, J. Wei, C. E. Marroquin, B. Clary, and P. C. Kuo (2005)
Carcinogenesis 26, 741-751
   Abstract »    Full Text »    PDF »
CD44 is a determinant of inflammatory bone loss.
S. Hayer, G. Steiner, B. Gortz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. (2005)
J. Exp. Med. 201, 903-914
   Abstract »    Full Text »    PDF »
The Cytokine Osteopontin Modulates the Severity of Rotavirus Diarrhea.
E. E. Rollo, S. J. Hempson, A. Bansal, E. Tsao, I. Habib, S. R. Rittling, D. T. Denhardt, E. R. Mackow, and R. D. Shaw (2005)
J. Virol. 79, 3509-3516
   Abstract »    Full Text »    PDF »
Dmp1-deficient Mice Display Severe Defects in Cartilage Formation Responsible for a Chondrodysplasia-like Phenotype.
L. Ye, Y. Mishina, D. Chen, H. Huang, S. L. Dallas, M. R. Dallas, P. Sivakumar, T. Kunieda, T. W. Tsutsui, A. Boskey, et al. (2005)
J. Biol. Chem. 280, 6197-6203
   Abstract »    Full Text »    PDF »
Hyaluronic Acid Induces Osteopontin via the Phosphatidylinositol 3-Kinase/Akt Pathway to Enhance the Motility of Human Glioma Cells.
M.-S. Kim, M.-J. Park, E.-J. Moon, S.-J. Kim, C.-H. Lee, H. Yoo, S.-H. Shin, E.-S. Song, and S.-H. Lee (2005)
Cancer Res. 65, 686-691
   Abstract »    Full Text »    PDF »
Soluble CD44 Is Cytotoxic to Trabecular Meshwork and Retinal Ganglion Cells In Vitro.
J. Choi, A. M. Miller, M. J. Nolan, B. Y. J. T. Yue, S. T. Thotz, A. F. Clark, N. Agarwal, and P. A. Knepper (2005)
Invest. Ophthalmol. Vis. Sci. 46, 214-222
   Abstract »    Full Text »    PDF »
Comparison of Gene Expression of Umbilical Cord Vein and Bone Marrow-Derived Mesenchymal Stem Cells.
R. A. Panepucci, J. L.C. Siufi, W. A. Silva Jr., R. Proto-Siquiera, L. Neder, M. Orellana, V. Rocha, D. T. Covas, and M. A. Zago (2004)
Stem Cells 22, 1263-1278
   Abstract »    Full Text »    PDF »
Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis.
L. Hu, M. Lee, W. Campbell, R. Perez-Soler, and S. Karpatkin (2004)
Blood 104, 2746-2751
   Abstract »    Full Text »    PDF »
Nuclear Factor-inducing Kinase Plays a Crucial Role in Osteopontin-induced MAPK/I{kappa}B{alpha} Kinase-dependent Nuclear Factor {kappa}B-mediated Promatrix Metalloproteinase-9 Activation.
H. Rangaswami, A. Bulbule, and G. C. Kundu (2004)
J. Biol. Chem. 279, 38921-38935
   Abstract »    Full Text »    PDF »
Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis.
M. Gattorno, A. Gregorio, F. Ferlito, V. Gerloni, A. Parafioriti, E. Felici, E. Sala, C. Gambini, P. Picco, and A. Martini (2004)
Rheumatology 43, 1091-1096
   Abstract »    Full Text »    PDF »
Bone Sialoprotein, Matrix Metalloproteinase 2, and {alpha}v{beta}3 Integrin in Osteotropic Cancer Cell Invasion.
A. Karadag, K. U. E. Ogbureke, N. S. Fedarko, and L. W. Fisher (2004)
J Natl Cancer Inst 96, 956-965
   Abstract »    Full Text »    PDF »
Osteopontin Induces AP-1-mediated Secretion of Urokinase-type Plasminogen Activator through c-Src-dependent Epidermal Growth Factor Receptor Transactivation in Breast Cancer Cells.
R. Das, G. H. Mahabeleshwar, and G. C. Kundu (2004)
J. Biol. Chem. 279, 11051-11064
   Abstract »    Full Text »    PDF »
Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma.
J. Koopmann, N. S. Fedarko, A. Jain, A. Maitra, C. Iacobuzio-Donahue, A. Rahman, R. H. Hruban, C. J. Yeo, and M. Goggins (2004)
Cancer Epidemiol. Biomarkers Prev. 13, 487-491
   Abstract »    Full Text »
Osteopontin affects the persistence of {beta}-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms.
J. Morimoto, M. Inobe, C. Kimura, S. Kon, H. Diao, M. Aoki, T. Miyazaki, D. T. Denhardt, S. Rittling, and T. Uede (2004)
Int. Immunol. 16, 477-488
   Abstract »    Full Text »    PDF »
CD44 Deficiency Increases Tubular Damage But Reduces Renal Fibrosis in Obstructive Nephropathy.
K. M.A. Rouschop, M. E. Sewnath, N. Claessen, J. J.T.H. Roelofs, I. Hoedemaeker, R. van der Neut, J. Aten, S. T. Pals, J. J. Weening, and S. Florquin (2004)
J. Am. Soc. Nephrol. 15, 674-686
   Abstract »    Full Text »    PDF »
The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events.
R. F. Thorne, J. W. Legg, and C. M. Isacke (2004)
J. Cell Sci. 117, 373-380
   Abstract »    Full Text »    PDF »
Correlation of Osteopontin Protein Expression and Pathological Stage across a Wide Variety of Tumor Histologies.
D. Coppola, M. Szabo, D. Boulware, P. Muraca, M. Alsarraj, A. F. Chambers, and T. J. Yeatman (2004)
Clin. Cancer Res. 10, 184-190
   Abstract »    Full Text »    PDF »
Calcium Oxalate Crystal Adherence to Hyaluronan-, Osteopontin-, and CD44-Expressing Injured/Regenerating Tubular Epithelial Cells in Rat Kidneys.
M. Asselman, A. Verhulst, M. E. de Broe, and C. F. Verkoelen (2003)
J. Am. Soc. Nephrol. 14, 3155-3166
   Abstract »    Full Text »    PDF »
Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
P.-L. Chang, M. Cao, and P. Hicks (2003)
Carcinogenesis 24, 1749-1758
   Abstract »    Full Text »    PDF »
Osteopontin: Roles in Implantation and Placentation.
G. A. Johnson, R. C. Burghardt, F. W. Bazer, and T. E. Spencer (2003)
Biol Reprod 69, 1458-1471
   Abstract »    Full Text »    PDF »
{beta}3 Integrin Expression Increases Breast Carcinoma Cell Responsiveness to the Malignancy-Enhancing Effects of Osteopontin.
K. A. Furger, A. L. Allan, S. M. Wilson, C. Hota, S. A. Vantyghem, C. O. Postenka, W. Al-Katib, A. F. Chambers, and A. B. Tuck (2003)
Mol. Cancer Res. 1, 810-819
   Abstract »    Full Text »    PDF »
Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by {beta}3 integrin.
R. Faccio, D. V. Novack, A. Zallone, F. P. Ross, and S. L. Teitelbaum (2003)
J. Cell Biol. 162, 499-509
   Abstract »    Full Text »    PDF »
Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in Osteoclasts.
M. A. Chellaiah, R. S. Biswas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska (2003)
J. Biol. Chem. 278, 29086-29097
   Abstract »    Full Text »    PDF »
Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis.
D. Leali, P. Dell'Era, H. Stabile, B. Sennino, A. F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta (2003)
J. Immunol. 171, 1085-1093
   Abstract »    Full Text »    PDF »
Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.
L. A. Ortiz, F. Gambelli, C. McBride, D. Gaupp, M. Baddoo, N. Kaminski, and D. G. Phinney (2003)
PNAS 100, 8407-8411
   Abstract »    Full Text »    PDF »
CD44v7 interferes with activation-induced cell death by up-regulation of anti-apoptotic gene expression.
R. Marhaba, M. Bourouba, and M. Zoller (2003)
J. Leukoc. Biol. 74, 135-148
   Abstract »    Full Text »    PDF »
Osteopontin Is Synthesized by Uterine Glands and a 45-kDa Cleavage Fragment Is Localized at the Uterine-Placental Interface Throughout Ovine Pregnancy.
G. A. Johnson, R. C. Burghardt, M. M. Joyce, T. E. Spencer, F. W. Bazer, C. A. Gray, and C. Pfarrer (2003)
Biol Reprod 69, 92-98
   Abstract »    Full Text »    PDF »
Osteopontin Induces Nuclear Factor kappa B-mediated Promatrix Metalloproteinase-2 Activation through Ikappa Balpha /IKK Signaling Pathways, and Curcumin (Diferulolylmethane) Down-regulates These Pathways.
S. Philip and G. C. Kundu (2003)
J. Biol. Chem. 278, 14487-14497
   Abstract »    Full Text »    PDF »
Functional Roles of Hyaluronan in B16-F10 Melanoma Growth and Experimental Metastasis in Mice.
M. E. Mummert, D. I. Mummert, L. Ellinger, and A. Takashima (2003)
Mol. Cancer Ther. 2, 295-300
   Abstract »    Full Text »    PDF »
A Role for {alpha}v{beta}3 Integrin During Implantation in the Rabbit Model.
M. J. Illera, P.L. Lorenzo, Y.-t. Gui, S. A. Beyler, K.B.C. Apparao, and B. A. Lessey (2003)
Biol Reprod 68, 766-771
   Abstract »    Full Text »    PDF »
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine.
C. Li, C. W. Yang, W. Y. Kim, J. Y. Jung, J. H. Cha, Y. S. Kim, J. Kim, W. M. Bennett, and B. K. Bang (2003)
Am J Physiol Renal Physiol 284, F389-F398
   Abstract »    Full Text »    PDF »
Crystal Retention Capacity of Cells in the Human Nephron: Involvement of CD44 and Its Ligands Hyaluronic Acid and Osteopontin in the Transition of a Crystal Binding- into a Nonadherent Epithelium.
A. Verhulst, M. Asselman, V. P. Persy, M. S.J. Schepers, M. F. Helbert, C. F. Verkoelen, and M. E. De Broe (2003)
J. Am. Soc. Nephrol. 14, 107-115
   Abstract »    Full Text »    PDF »
Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression.
M. A. Chellaiah, N. Kizer, R. Biswas, U. Alvarez, J. Strauss-Schoenberger, L. Rifas, S. R. Rittling, D. T. Denhardt, and K. A. Hruska (2003)
Mol. Biol. Cell 14, 173-189
   Abstract »    Full Text »
Serial analysis of gene expression in murine fetal thymocyte cell lines.
F.-Q. Zhao, Z.-M. Sheng, M. M. Tsai, A. E. Hubbs, R. Wang, T. J. O'Leary, D. J. Izon, and J. K. Taubenberger (2002)
Int. Immunol. 14, 1383-1395
   Abstract »    Full Text »    PDF »
Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation.
G. F. Weber, S. Zawaideh, S. Hikita, V. A. Kumar, H. Cantor, and S. Ashkar (2002)
J. Leukoc. Biol. 72, 752-761
   Abstract »    Full Text »    PDF »
Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation.
K. Isoda, K. Nishikawa, Y. Kamezawa, M. Yoshida, M. Kusuhara, M. Moroi, N. Tada, and F. Ohsuzu (2002)
Circ. Res. 91, 77-82
   Abstract »    Full Text »    PDF »
Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
D. J. Kelly, J. L. Wilkinson-Berka, S. D. Ricardo, A. J. Cox, and R. E. Gilbert (2002)
Nephrol. Dial. Transplant. 17, 985-991
   Abstract »    Full Text »    PDF »
Hypoxia Differentially Enhances the Effects of Transforming Growth Factor-beta Isoforms on the Synthesis and Secretion of Glycosaminoglycans by Human Lung Fibroblasts.
E. Papakonstantinou, M. Roth, M. Tamm, O. Eickelberg, A. P. Perruchoud, and G. Karakiulakis (2002)
J. Pharmacol. Exp. Ther. 301, 830-837
   Abstract »    Full Text »    PDF »
Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer.
P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West (2002)
Cancer Res. 62, 3417-3427
   Abstract »    Full Text »    PDF »
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer.
J.-H. Kim, S. J. Skates, T. Uede, K.-k. Wong, J. O. Schorge, C. M. Feltmate, R. S. Berkowitz, D. W. Cramer, and S. C. Mok (2002)
JAMA 287, 1671-1679
   Abstract »    Full Text »    PDF »
Absence of the CD44 Gene Prevents Sarcoma Metastasis.
G. F. Weber, R. T. Bronson, J. Ilagan, H. Cantor, R. Schmits, and T. W. Mak (2002)
Cancer Res. 62, 2281-2286
   Abstract »    Full Text »    PDF »
Tumor-derived Osteopontin Is Soluble, Not Matrix Associated.
S. R. Rittling, Y. Chen, F. Feng, and Y. Wu (2002)
J. Biol. Chem. 277, 9175-9182
   Abstract »    Full Text »    PDF »
Cutting Edge: Attenuated Experimental Autoimmune Encephalomyelitis in Eta-1/Osteopontin-Deficient Mice.
M. Jansson, V. Panoutsakopoulou, J. Baker, L. Klein, and H. Cantor (2002)
J. Immunol. 168, 2096-2099
   Abstract »    Full Text »    PDF »
Contrasting Expression of Thrombospondin-1 and Osteopontin Correlates with Absence or Presence of Metastatic Phenotype in an Isogenic Model of Spontaneous Human Breast Cancer Metastasis.
V. Urquidi, D. Sloan, K. Kawai, D. Agarwal, A. C. Woodman, D. Tarin, and S. Goodison (2002)
Clin. Cancer Res. 8, 61-74
   Abstract »    Full Text »    PDF »
The Osteopontin-CD44 Survival Signal Involves Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Y.-H. Lin and H.-F. Yang-Yen (2001)
J. Biol. Chem. 276, 46024-46030
   Abstract »